127 related articles for article (PubMed ID: 38697478)
1. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury.
Feng Y; Sun Z; Fu J; Zhong F; Zhang W; Wei C; Chen A; Liu BC; He JC; Lee K
Kidney Int; 2024 Apr; ():. PubMed ID: 38697478
[TBL] [Abstract][Full Text] [Related]
2. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
3. Disparate roles of retinoid acid signaling molecules in kidney disease.
Chen A; Liu Y; Lu Y; Lee K; He JC
Am J Physiol Renal Physiol; 2021 May; 320(5):F683-F692. PubMed ID: 33645319
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharide alleviates angiotensin II-induced glomerular podocyte dysfunction by inhibiting the expression of RARRES1 and LCN2.
Peng L; Zhang C; Xiao G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):504-515. PubMed ID: 36876579
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor responder1 promotes development of glomerular diseases via the Nuclear Factor-κB signaling pathway.
Möller-Hackbarth K; Dabaghie D; Charrin E; Zambrano S; Genové G; Li X; Wernerson A; Lal M; Patrakka J
Kidney Int; 2021 Oct; 100(4):809-823. PubMed ID: 34147551
[TBL] [Abstract][Full Text] [Related]
6. Autocrine and paracrine effects of a novel podocyte gene, RARRES1.
Chen A; Lee K; He JC
Kidney Int; 2021 Oct; 100(4):745-747. PubMed ID: 34556297
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
8. AMPK mediates regulation of glomerular volume and podocyte survival.
Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
[TBL] [Abstract][Full Text] [Related]
9. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
10. Podocyte injury at young age causes premature senescence and worsens glomerular aging.
Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
12. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
13. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
[TBL] [Abstract][Full Text] [Related]
14. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
15. Tyro3 is a podocyte protective factor in glomerular disease.
Zhong F; Chen Z; Zhang L; Xie Y; Nair V; Ju W; Kretzler M; Nelson RG; Li Z; Chen H; Wang Y; Zhang A; Lee K; Liu Z; He JC
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429374
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
[TBL] [Abstract][Full Text] [Related]
17. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
19. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis.
Zhuang Q; Li F; Liu J; Wang H; Tian Y; Zhang Z; Wang F; Zhao Z; Chen J; Wu H
Lab Invest; 2021 Feb; 101(2):258-270. PubMed ID: 33203894
[TBL] [Abstract][Full Text] [Related]
20. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice.
Chuang PY; Cai W; Li X; Fang L; Xu J; Yacoub R; He JC; Lee K
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F621-F628. PubMed ID: 28615249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]